Brought to you by 
Reckitt gets exclusive rights to seven BMS OTC products in Latin America
Feb 2013
Executive Summary
For the next three years, consumer and personal care company Reckitt Benckiser Group PLC will exclusively market seven of Bristol-Myers Squibb Co.’s OTC products in Latin America. Together this portfolio achieved $102mm in 2012 net revenue.
Deal Industry
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Reverse Licensing
- Marketing-Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com